These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 5257887)
1. Comparative performance of equivalent drugs. Some questions and answers. Levy G Med Ann Dist Columbia; 1969 Jun; 38(6):301-2 passim. PubMed ID: 5257887 [No Abstract] [Full Text] [Related]
3. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
4. Improving drug quality through certification experience. Weiss PJ Am J Pharm Sci Support Public Health; 1974; 146(3):86-90. PubMed ID: 4852375 [No Abstract] [Full Text] [Related]
5. Comparative performance of equivalent drugs. Murray WJ Med Ann Dist Columbia; 1969 Jun; 38(6):295-6. PubMed ID: 5257885 [No Abstract] [Full Text] [Related]
6. New classification of drugs. J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956 [No Abstract] [Full Text] [Related]
7. F.D.A. to assess O.T.C. drugs for safety, efficacy, labeling. Bowles GC Mod Hosp; 1972 Mar; 118(3):126. PubMed ID: 5058060 [No Abstract] [Full Text] [Related]
8. Drugs, codes, standards, and other incompatible things in the dark. Chute CG MD Comput; 2001; 18(1):45-6. PubMed ID: 11236386 [No Abstract] [Full Text] [Related]
9. Drug safety: the viewpoint of the pharmaceutical manufacturing industry. Wigle WW Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099 [No Abstract] [Full Text] [Related]
10. Safety-related drug labeling changes approved by FDA. White GG J Toxicol Clin Toxicol; 1998; 36(3):265-7. PubMed ID: 9678979 [No Abstract] [Full Text] [Related]
11. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk. Murphy S; Roberts R J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581 [TBL] [Abstract][Full Text] [Related]
12. Drug advisory committees. Getting outside advice for close calls. Farley D FDA Consum; 1995 Mar; 29(2):23-6. PubMed ID: 10172354 [No Abstract] [Full Text] [Related]
13. The status of unit-of-use in Europe and the United States: an evolution in drug dispensing. Archambault GF Hosp Formul; 1979 Jan; 14(1):70-1, 75-6, 78-9. PubMed ID: 10297341 [No Abstract] [Full Text] [Related]
15. Development of orphan products. FDA Drug Bull; 1983 Apr; 13(1):2-4. PubMed ID: 6852406 [No Abstract] [Full Text] [Related]
16. Anticounterfeit campaigners go back to school. Dolgin E Nat Med; 2010 Apr; 16(4):362. PubMed ID: 20376028 [No Abstract] [Full Text] [Related]
17. The concept of drug expiration dating. Wollish EG Bull Parenter Drug Assoc; 1969; 23(1):48-52. PubMed ID: 5765721 [No Abstract] [Full Text] [Related]
18. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk. Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527 [No Abstract] [Full Text] [Related]